These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12722315)

  • 1. [Antiprotozoal drugs].
    Nakajima Y
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():774-9. PubMed ID: 12722315
    [No Abstract]   [Full Text] [Related]  

  • 2. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in immunodiagnosis and chemotherapy of protozoan infections].
    von Sonnenburg F; Prüfer L
    Internist (Berl); 1983 Nov; 24(11):599-609. PubMed ID: 6360942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs used against protozoan infections in man].
    Takada S
    Nihon Rinsho; 1990 Oct; 48(10):2228-33. PubMed ID: 2280469
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria.
    Karbwang J; Back DJ; Bunnag D; Breckenridge AM
    Bull World Health Organ; 1990; 68(5):633-8. PubMed ID: 2289299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparasitic drugs.
    Yoshikawa TT
    Am Fam Physician; 1980 Mar; 21(3):132-8. PubMed ID: 7355683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroheterocyclic drugs with broad spectrum activity.
    Raether W; Hänel H
    Parasitol Res; 2003 Jun; 90 Supp 1():S19-39. PubMed ID: 12811546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
    Myint PT; Shwe T
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of antimalarial drugs.
    Baird JK
    N Engl J Med; 2005 Apr; 352(15):1565-77. PubMed ID: 15829537
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
    Ghosh SK; Yadav RS; Sharma VP
    Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Aminoquinolines: future role as antiprotozoal drugs.
    Tekwani BL; Walker LA
    Curr Opin Infect Dis; 2006 Dec; 19(6):623-31. PubMed ID: 17075340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
    Salako LA
    Ann Ist Super Sanita; 1985; 21(3):315-25. PubMed ID: 3914849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurological toxicity of antifungal and antiprotozoal drugs].
    Suzuki M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):564-7. PubMed ID: 10434722
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole is still the drug of choice for treatment of anaerobic infections.
    Löfmark S; Edlund C; Nord CE
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S16-23. PubMed ID: 20067388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
    Denis MB; Kouznetsov RL; Giboda M
    Folia Parasitol (Praha); 1991; 38(2):187-8. PubMed ID: 1937278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.